ORIG3N Obtains $3,100,000 New Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    27 Drydock Ave. Boston, MA 02210 USA
  • Company Description
    Boston based ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases with targets in heart, liver and neurodegenerative indications. These treatments are based upon Nobel Prize winning technology.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    The funding will be used to expand Life Capsule which provides everyone the opportunity to contribute to the advancement of medical research of rare genetic inherited diseases and neurodegenerative diseases such as Parkinson’s, Alzheimer’s, MS and ALS.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy